Abstract:Interphotoreceptor retinoid-binding protein (IRBP) greatly enhances the conversion of all- trans -retinol to 11- cis -retinal by the retinal pigment epithelium (RPE) and facilitates 11- cis -retinal release from the RPE. However, the mechanisms by which IRBP exerts these effects are not clear. Using a model system of purified bovine IRBP and isolated bovine RPE membranes, we investigated the possibility that IRBP may favor the delivery of all- trans -retinol to, or the release of 11- cis -retinal from, RPE membranes. As the interphotoreceptor space contains serum retinol-binding protein (RBP) and serum albumin in addition to IRBP, we similarly examined the exchange of retinoids between RPE membranes and human RBP or bovine serum albumin (BSA). Isolated RPE membranes were loaded with radioactive 11- cis -retinal and incubated with solutions of IRBP, RBP, BSA or with buffer alone. Membranes (pellet) and retinoid-binding protein or buffer (supernatant) were separated by centrifugation and analysed for radioactive 11- cis -retinal. Membranes incubated with buffer alone released only 4-5% of their 11- cis -retinal, while 25 microm IRBP removed 18-35%. More retinal was released as the membrane concentration was reduced. In contrast, RBP and BSA removed little retinal, even though both proteins are capable of binding this retinoid. Similar results were obtained with bovine liver membranes, consistent with the idea that the effects of IRBP do not depend on an RPE surface receptor for IRBP. IRBP was also markedly superior to RBP and BSA in removing all- trans -retinol from RPE membranes. In addition, IRBP efficiently delivered bound all- trans -retinol to membranes; however, in contrast to their differential removal of retinoids, all three binding proteins delivered comparable amounts of retinol to membranes. (This result supports the practice of using BSA as a retinoid carrier in in vitro experimental systems). We conclude that, whereas IRBP shares with other retinoid-binding proteins the ability to deliver retinol to membranes, IRBP is unique in its capacity to remove 11- cis -retinal from membranes. This may be the feature of IRBP that drives the vitamin A cycle to efficiently produce 11- cis -retinal.

[Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].

Nonlinear Multilevel Joint Model for Individual Lesion Kinetics and Survival to Characterize Intra-Individual Heterogeneity in Patients with Advanced Cancer

A multi-state model incorporating estimation of excess hazards and multiple time scales

Combined Stochastic Models for the Evaluation of Cancer Progression and Patient Trajectories

Patterns and predictors of follow-up in patients with mild traumatic brain injury

A joint model for (un)bounded longitudinal markers, competing risks, and recurrent events using patient registry data

Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer

Immunological mutants of the mouse.

A Bayesian joint model of multiple nonlinear longitudinal and competing risks outcomes for dynamic prediction in multiple myeloma: joint estimation and corrected two-stage approaches

Lifespan and medical expenditure prognosis for cancer metastasis - a simulation modeling using semi-Markov process

Joint longitudinal and time-to-event models for multilevel hierarchical data

Bridging the gap between two‐stage and joint models: The case of tumor growth inhibition and overall survival models

Joint Dynamic Models and Statistical Inference for Recurrent Competing Risks, Longitudinal Marker, and Health Status

A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data

Nonlinear Mixed-Effect Models for Prostate-Specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: a Comparison by Simulation of Two-Stage and Joint Approaches

Multi-stage models for the failure of complex systems, cascading disasters, and the onset of disease

Separable pathway effects of semi-competing risks using multi-state models

IRBP enhances removal of 11- cis -retinaldehyde from isolated RPE membranes.

[Application of Multi-Stage Competing Risk Model to Survival Data].

Reflection on modern methods: competing risks versus multi-state models

Cancer recurrence times from a branching process model